Therefore, the current study was performed in order to analyze retrospectively the predictive value of Ki-67 in prediction of responses of breast cancer patients to neoadjuvant chemotherapy treatment conducted in a German university hospital. This evidence concerns the gene MKI67 and breast cancer.